Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 24% ± 8% | |
alveolar macrophage | 3 studies | 21% ± 8% |
Insufficient scRNA-seq data for expression of ARRDC4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 2329.40 | 245 / 245 | 99% | 24.02 | 497 / 502 |
thymus | 100% | 3554.97 | 652 / 653 | 99% | 27.95 | 597 / 605 |
kidney | 100% | 4288.07 | 89 / 89 | 97% | 43.22 | 871 / 901 |
breast | 100% | 1846.77 | 459 / 459 | 95% | 23.60 | 1064 / 1118 |
pancreas | 98% | 2425.11 | 323 / 328 | 97% | 34.81 | 172 / 178 |
intestine | 100% | 7045.13 | 966 / 966 | 94% | 23.68 | 496 / 527 |
lung | 99% | 3218.26 | 574 / 578 | 93% | 23.10 | 1076 / 1155 |
stomach | 100% | 4444.30 | 359 / 359 | 92% | 23.22 | 262 / 286 |
brain | 92% | 2222.69 | 2430 / 2642 | 99% | 50.75 | 701 / 705 |
esophagus | 98% | 4017.47 | 1410 / 1445 | 93% | 33.14 | 170 / 183 |
uterus | 100% | 2579.52 | 170 / 170 | 89% | 19.11 | 408 / 459 |
adrenal gland | 98% | 2389.91 | 253 / 258 | 90% | 18.99 | 208 / 230 |
bladder | 100% | 3056.90 | 21 / 21 | 84% | 16.34 | 422 / 504 |
skin | 89% | 3434.37 | 1615 / 1809 | 90% | 35.85 | 427 / 472 |
liver | 87% | 1395.68 | 197 / 226 | 67% | 15.13 | 272 / 406 |
ovary | 91% | 1383.79 | 163 / 180 | 56% | 7.85 | 242 / 430 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.41 | 1 / 1 |
adipose | 99% | 1929.47 | 1190 / 1204 | 0% | 0 | 0 / 0 |
spleen | 99% | 1627.84 | 238 / 241 | 0% | 0 | 0 / 0 |
muscle | 93% | 1603.47 | 743 / 803 | 0% | 0 | 0 / 0 |
heart | 90% | 1536.42 | 777 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 89% | 1269.48 | 1191 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 87% | 19.90 | 39 / 45 |
lymph node | 0% | 0 | 0 / 0 | 66% | 9.56 | 19 / 29 |
eye | 0% | 0 | 0 / 0 | 50% | 6.00 | 40 / 80 |
peripheral blood | 35% | 471.88 | 325 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0015031 | Biological process | protein transport |
GO_0016567 | Biological process | protein ubiquitination |
GO_0032728 | Biological process | positive regulation of interferon-beta production |
GO_0140112 | Biological process | extracellular vesicle biogenesis |
GO_0070534 | Biological process | protein K63-linked ubiquitination |
GO_0051443 | Biological process | positive regulation of ubiquitin-protein transferase activity |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_1903561 | Cellular component | extracellular vesicle |
GO_0005768 | Cellular component | endosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005769 | Cellular component | early endosome |
GO_1990756 | Molecular function | ubiquitin-like ligase-substrate adaptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ARRDC4 |
Protein name | Arrestin domain-containing protein 4 |
Synonyms | |
Description | FUNCTION: Functions as an adapter recruiting ubiquitin-protein ligases to their specific substrates (By similarity). Plays a role in endocytosis of activated G protein-coupled receptors (GPCRs) (Probable). Through an ubiquitination-dependent mechanism also plays a role in the incorporation of SLC11A2 into extracellular vesicles (By similarity). May play a role in glucose uptake . Participates in innate immune response by promoting IFIH1/MDA5 activation through interaction with TRIM65 . . |
Accessions | Q8NCT1 ENST00000268042.7 |